| Asthma |
1 |
1 |
| Generics |
0 |
0.8 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.99 |
| Otolaryngology |
0 |
0.55 |
| Food and Drug Administration (FDA) |
0 |
0.98 |
| Metered-Dose Inhaler (MDI) |
0 |
0.38 |
| Fungal Infection |
0 |
0.37 |
| Inhalers |
0 |
0.31 |
| Oral Candidiasis |
0 |
0.27 |
| Candidiasis |
0 |
0.23 |
| Dentistry and Oral Health |
0 |
0.23 |
| Skin and Soft Tissue Infection |
0 |
0.19 |
| Pain Management |
0 |
0.17 |
| Chronic Bronchitis |
0 |
0.16 |
| Adverse Effects |
0 |
0.15 |
| Bronchitis |
0 |
0.15 |
| Nasopharyngitis |
0 |
0.15 |
| Pain |
0 |
0.15 |
| Sinusitis |
0 |
0.15 |
| Back Pain |
0 |
0.14 |
| Patient Safety |
0 |
0.13 |
| Upper Respiratory Tract Infection |
0 |
0.11 |
| Airway |
0 |
0.08 |
| Bronchodilator |
0 |
0.08 |
| Corticosteroids |
0 |
0.08 |
| Dorsum |
0 |
0.08 |
| Emphysema |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Muscle |
0 |
0.08 |
| Nasal Congestion |
0 |
0.08 |
| Quality of Life |
0 |
0.08 |
| Respiratory Tract |
0 |
0.08 |
| Stomach |
0 |
0.08 |
| Influenza |
0 |
0.06 |